Safety, Pharmacokinetics, and Antiviral Activity of a Novel HIV Antiviral, ABX464, in Treatment-Naive HIV-Infected Subjects in a Phase 2 Randomized, Controlled Study.
Steens JM, Scherrer D, Gineste P, Barrett PN, Khuanchai S, Winai R, Ruxrungtham K, Tazi J, Murphy R, Ehrlich H.
2017
Antimicrob Agents Chemother.
2017 Jun 27 / vol 61(7) / pages pii: e00545-17
Abstract
10.1128/AAC.00545-17